Upstream Bio (UPB) Change in Accured Expenses (2023 - 2026)

Upstream Bio's Change in Accured Expenses history runs 4 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 166.4% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $7.1 million (up 1201.65% YoY), while the FY2025 annual figure was $4.0 million, up 165.48% from the prior year.
• Change in Accured Expenses was $1.2 million for Q1 2026 at Upstream Bio, down from $2.8 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $3.5 million in Q2 2025 to a low of -$1.9 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged $739400.0 across 4 years, with a median of $510500.0 in 2023.
• Biggest YoY gain for Change in Accured Expenses was 822.77% in 2025; the steepest drop was 285.71% in 2025.
• A 4-year view of Change in Accured Expenses shows it stood at $639000.0 in 2023, then surged by 174.65% to $1.8 million in 2024, then surged by 60.74% to $2.8 million in 2025, then tumbled by 56.43% to $1.2 million in 2026.
• The last three Change in Accured Expenses figures came in at $1.2 million (Q1 2026), $2.8 million (Q4 2025), and -$481000.0 (Q3 2025), per Business Quant data.